 |
|
|
| |
Association Between Early Virologic Response and Immunologic Outcomes in Raltegravir-treated Patients
|
| |
| |
Reported by Jules Levin
CROI 2013
C. Tsoukas1, A. Rodgers2, H. Teppler2, R. Leavitt2, B-Y. Nguyen2, P. Sklar2
1McGill University, Montreal, Canada; 2Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA
|
| |
|
|
|
|
|
